Stek advises shareholders of CAM Bioceramics in sale of majority stake to SHS Capital and ING Corporate Investments

The shareholders of CAM Bioceramics have sold a majority stake to SHS Capital, a German investor specialising in healthcare, and ING Corporate Investments and will remain involved as minority shareholders.

Bioceramics, based in Leiden, the Netherlands, is a leading global producer of innovative calcium phosphate solutions for Medtech and LifeScience applications.

Click here for the press release.

This might also interest you

Stek victorious for distribution system operator Liander in transmission capacity dispute

Stek successfully represented distribution system operator Liander in summary proceedings before the Gelderland District Court against one of its customers. …

Stek advised Foresco Group on the acquisition of De Haan Palletindustrie/UPC Pallets and Pallethandel De Boer

De Haan Palletindustrie/UPC Pallets and Pallethandel De Boer have become part of the Foresco Group as of 31 January 2024. …

Stek victorious for Eneco in appeal against Advertising Code Committee decision on sustainability claim and communication of sustainability ambition

Stek has successfully represented energy supplier Eneco in an appeal procedure before the Board of Appeal of the Advertising Code …